Cleared Special

K233853 - LumiGuide Wire

Also marketed or referenced as:
LumiGuide Equipment R2.0 LumiGuide 3D Hub

K233853 is the FDA 510(k) clearance for LumiGuide Wire by Philips Medical Systems Nederland B.V.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Special 510(k) pathway after a 100-day FDA review.

K233853 · Philips Medical Systems Nederland B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
100d
Days
Class 2
Risk

K233853 is an FDA 510(k) clearance for the LumiGuide Wire. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (Best, NL). The FDA issued a Cleared decision on March 14, 2024 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Philips Medical Systems Nederland B.V. devices

Submission Details

510(k) Number K233853 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2023
Decision Date March 14, 2024
Days to Decision 100 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 125d · This submission: 100d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K233853.
STAR Apollo™ Mapping System
K240509 · Rhythm AI, Ltd. · Jul 2024
Intra-Operative Positioning System (IOPS®) Viewpoint (Simple Curve Catheters)
K241243 · Centerline Biomedical, Inc. · Jul 2024
Merge Hemo, Model RCSV2
K233326 · Merge Healthcare Incorporated · Jun 2024
Affera Mapping System (AFR-00003)
K233943 · Medtronic, Inc. · Mar 2024
CASE V7.0 Cardiac Testing System and CardioSoft V7.0 Cardiac Testing System
K231870 · Ge Medical Systems Information Technologies, Inc. · Dec 2023
NeuTrace EP Mapping System v.2.1
K233160 · Anumana, Inc. · Nov 2023